Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
Shi Q, Flowers CR, Hiddemann W, Marcus R, Herold M, Hagenbeek A, Kimby E, Hochster H, Vitolo U, Peterson BA, Gyan E, Ghielmini M, Nielsen T, De Bedout S, Fu T, Valente N, Fowler NH, Hoster E, Ladetto M, Morschhauser F, Zucca E, Salles G, Sargent DJ. Shi Q, et al. Among authors: ghielmini m. J Clin Oncol. 2017 Feb 10;35(5):552-560. doi: 10.1200/JCO.2016.70.8651. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029309
How I treat mantle cell lymphoma.
Ghielmini M, Zucca E. Ghielmini M, et al. Blood. 2009 Aug 20;114(8):1469-76. doi: 10.1182/blood-2009-02-179739. Epub 2009 Jun 25. Blood. 2009. PMID: 19556426 Free article. Review.
Open questions in the management of mantle cell lymphoma.
Li ZM, Zucca E, Ghielmini M. Li ZM, et al. Among authors: ghielmini m. Cancer Treat Rev. 2013 Oct;39(6):602-9. doi: 10.1016/j.ctrv.2012.12.013. Epub 2013 Feb 13. Cancer Treat Rev. 2013. PMID: 23415066 Review.
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Taverna C, Martinelli G, Hitz F, Mingrone W, Pabst T, Cevreska L, Del Giglio A, Vanazzi A, Laszlo D, Raats J, Rauch D, Vorobiof DA, Lohri A, Biaggi Rudolf C, Rondeau S, Rusterholz C, Heijnen IA, Zucca E, Ghielmini M. Taverna C, et al. Among authors: ghielmini m. J Clin Oncol. 2016 Feb 10;34(5):495-500. doi: 10.1200/JCO.2015.61.3968. Epub 2015 Dec 28. J Clin Oncol. 2016. PMID: 26712227 Free PMC article. Clinical Trial.
Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How.
Pavanello F, Steffanoni S, Ghielmini M, Zucca E. Pavanello F, et al. Among authors: ghielmini m. Mediterr J Hematol Infect Dis. 2016 Nov 7;8(1):e2016062. doi: 10.4084/MJHID.2016.062. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 27872742 Free PMC article. Review.
Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
Vidal L, Gafter-Gvili A, Salles G, Bousseta S, Oberman B, Rubin C, van Oers MH, Fortpied C, Ghielmini M, Pettengell R, Witzens-Harig M, Dreger P, Vitolo U, Gomes da Silva M, Evangelista A, Li H, Freedman L, Habermann TM, Shpilberg O. Vidal L, et al. Among authors: ghielmini m. Eur J Cancer. 2017 May;76:216-225. doi: 10.1016/j.ejca.2017.01.021. Epub 2017 Mar 21. Eur J Cancer. 2017. PMID: 28336303
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).
Moccia AA, Schär S, Hayoz S, Pirosa MC, Taverna C, Novak U, Kimby E, Ghielmini M, Zucca E. Moccia AA, et al. Among authors: ghielmini m. Br J Haematol. 2021 Mar;192(6):1031-1034. doi: 10.1111/bjh.17045. Epub 2020 Aug 17. Br J Haematol. 2021. PMID: 32805081 Free article. Clinical Trial.
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials.
Dixon JG, Çağlayan Ç, Chihara D, Nielsen T, Dimier N, Zheng J, Wall AK, Salles G, Morschhauser F, Marcus R, Herold M, Kimby E, Blum KA, Ghielmini M, Shi Q, Flowers CR. Dixon JG, et al. Among authors: ghielmini m. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):e1009-e1018. doi: 10.1016/j.clml.2022.07.015. Epub 2022 Aug 3. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36045021 Clinical Trial.
129 results